![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 209/04 | (2006.01) |
C07D 209/32 | (2006.01) | ||
A61P 31/14 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61K 31/4045 | (2006.01) |
(11) | Number of the document | 3601225 |
(13) | Kind of document | T |
(96) | European patent application number | 18715611.2 |
Date of filing the European patent application | 2018-03-29 | |
(97) | Date of publication of the European application | 2020-02-05 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
(46) | Date of publication of the claims translation | 2021-08-10 |
(86) | Number | PCT/EP2018/058077 |
Date | 2018-03-29 |
(87) | Number | WO 2018/178238 |
Date | 2018-10-04 |
(30) | Number | Date | Country code |
17164045 | 2017-03-31 | EP |
(72) |
BARDIOT, Dorothée Alice Marie-Eve , BE
KESTELEYN, Bart Rudolf Romanie , BE
BONFANTI, Jean-Francois , FR
RABOISSON, Pierre Jean-Marie Bernard , BE
MARCHAND, Arnaud Didier M , BE
|
(73) |
Janssen Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven , Waaistraat 6, bus 5105, 3000 Leuven, BE |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Pakeistieji indolino dariniai kaip dengės viruso replikacijos inhibitoriai |
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
Payment date | Validity (years) | Amount | |
2025-02-27 | 8 | 185.00 EUR |
2026-03-29 |